In all, six of the 37 studies focused on semaglutide or tirzepatide, and most trial data followed patients for less than one year, meaning longer-term results are estimates
Common Sensations: A temporary warm or flushed feeling in the face may occur shortly after use
Similarly, the EMA declined to grant Mounjaro an additional indication for obstructive sleep apnoea (OSA), unlike the FDA, instead only including data from relevant OSA trials in its label
PMC 6755949
Previous research indicates that GLP-1 drugs effectively reduce oxidative stress levels, inhibit the production of proinflammatory cytokines and modulate the recruitment of immune cells, thereby alleviating the inflammatory environment within the retina
Journal of Translational Medicine, 22 , 629